BioSpace News Archive

Lone Star Bio

DNAtrix to Present at the Raymond James Human Health Innovations Conference

DNAtrix, today announced that the company will present at the Raymond James Human Health Innovations Conference on Monday, June 21, 2021 , at 1:20 pm ET .

June 9, 2021
·
1 min read
Lone Star Bio

Plus Therapeutics to Participate in BIO Digital Conference

Plus Therapeutics, Inc. today announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will participate in the BIO Digital Conference being held June 10-11 and 14-18, 2021.

June 9, 2021
·
4 min read
Genetown

CENTOGENE to Announce Q1 2021 Financial Results on June 16, 2021

Centogene N.V. today announced that it will issue its financial results for the quarter ended March 31, 2021, on Wednesday, June 16, 2021.

June 9, 2021
·
4 min read
Bright Minds Biosciences to Present at the 2021 LD Micro Invitational XI

Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), today announced that Ian McDonald, Chief Executive Officer, and Dr. Gideon Shapiro Ph.D, Vice President of Discovery, will be presenting at the 2021 LD Micro Invitational XI,

June 9, 2021
·
1 min read
Business

AlloSource Honors Dr. David Argo With The Annual Dr. Steven Gitelis Inspiration Award

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, announced it is awarding Dr. David Argo with its fifth annual Dr. Steven Gitelis Inspiration Award.

June 9, 2021
·
2 min read
Pharm Country

Vapotherm to Host First Investor Day

Vapotherm, Inc. today announced that its management team will be hosting their first investor day on Wednesday, June 23, 2021 beginning at 10:00AM ET.

June 9, 2021
·
2 min read
Deals

VBI Vaccines Announces Results of Annual General Meeting - June 09, 2021

VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced the voting results from its annual general meeting of shareholders held on June 9, 2021.

June 9, 2021
·
2 min read
Biotech Bay

InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team

InCarda Therapeutics, Inc. (“InCarda”), today provided a broad corporate update highlighting significant progress for the company’s last-stage development program for InRhythm™ (flecainide for inhalation) in patients with atrial fibrillation, as well as the expansion of its senior management team.

June 9, 2021
·
8 min read
Deals

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome

Nautilus Biotechnology, Inc. announced the completion of its business combination with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors.

June 9, 2021
·
7 min read
BioForest

OnQuality Pharmaceuticals Announces Upcoming Presentation at 2021 BIO Digital

OnQuality Pharmaceuticals (“OnQuality”), today announced that it has been selected to deliver a company presentation at the Biotechnology Innovation Organization (BIO)'s 2021 BIO Digital International Convention.

June 9, 2021
·
4 min read